Table 3

Regression coefficients by clinical quality measure

	% Hypertensive	PCMH status	% Uninsured	Urban	% Poverty	% 65+	% Hispanic
Process measures (%)
Body mass index screening and follow-up plan	0.238***	0.067***	0.079*	−0.028	0.096**	−0.162	0.041
Cervical cancer screening	0.062	0.058*	−0.091**	0.052***	−0.105***	−0.073	0.167***
Childhood immunisation status	−0.198*	−0.023	−0.047	0.079*	−0.093*	0.111	0.144*
Colorectal cancer screening	0.222***	0.059***	−0.155***	0.030**	−0.109***	0.524***	0.109***
Coronary artery disease: lipid therapy	0.069	0.023**	0.026	0.005	−0.039	−0.160*	0.028
Dental sealants for children 6–9 years	−0.120	−0.000	0.018	−0.030	−0.027	−0.288	0.008
Early entry into prenatal care	−0.153**	0.026*	−0.157***	−0.024*	−0.099***	0.465***	0.017
Ischaemic vascular disease: use of aspirin or another antiplatelet	0.018	0.038***	−0.026	0.024**	−0.028	0.122	0.044***
Screening for depression and follow-up plan	0.255**	0.083***	0.062	−0.034*	−0.048	−0.520***	0.041
Tobacco use screening and cessation intervention	0.038	0.056***	−0.043*	−0.014	−0.019	0.054	0.060***
Use of appropriate medications for asthma	0.090	0.035**	−0.030	0.013	−0.045	−0.112	0.075***
Weight assessment and counselling for nutrition and physical activity for children and adolescents	0.232**	0.074***	−0.047	0.026	0.072	−0.283	0.102**
Outcome measures (%)
Controlling high blood pressure (<140/90 mm Hg)	0.001	0.013*	−0.121***	−0.011	−0.053**	0.119*	0.058***
Diabetes: aaemoglobin A1c poor control (>9)	−0.105**	−0.025**	0.078***	−0.005	0.088***	−0.330***	−0.025*
Low birth weight (% of live births)	0.089***	−0.000	−0.033***	0.009**	0.009	−0.106**	−0.026***

*P<0.05, **p<0.01, ***p<0.001.
PCMH, patient-centred medical home.